Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research-Reference-Cited by-同舟云学术

Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research

Published:2023-04-12 Issue:24 Volume:44 Page:2143-2145
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Sopic Miron¹²^ORCID,Kararigas Georgios³^ORCID,Devaux Yvan²^ORCID,Magni Paolo⁴^ORCID

Affiliation:

1. Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade , Vojvode Stepe 450, 11 000 Belgrade , Serbia

2. Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health , 1A-B rue Edison, L-1445 Strassen , Luxembourg

3. Department of Physiology, Faculty of Medicine, University of Iceland , Vatnsmyrarvegur 16, 101 Reykjavik , Iceland

4. Department of Pharmacological and Biomolecular Sciences ‘Rodolfo Paoletti’, Università degli Studi di Milano, Via G. Balzaretti 9, 20133 Milano, Italy and IRCCS MultiMedica , Via Milanese 300, 20099 Sesto S. Giovanni, Milan , Italy

Funder

Ministry of Education

Science and Technological Development

Republic of Serbia

Icelandic Research Fund

Icelandic Cancer Society Research Fund

University of Iceland Research Fund

EU Horizon 2020 project COVIRNA

National Research Fund

Universita’ degli Studi di Milano

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/24/2143/50699855/ehad153.pdf

Reference14 articles.

1. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014;Szummer;Eur Heart J,2017

2. European Society of Cardiology: cardiovascular disease statistics 2019;Timmis;Eur Heart J,2020

3. Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging;Crea;Eur Heart J,2023

4. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI);Bulluck;Eur Heart J,2021

5. What we (don’t) know about myocardial injury after COVID-19;Friedrich;Eur Heart J,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the path of reproducibility in microRNA-based biomarker research with ring trials;Clinical Chemistry and Laboratory Medicine (CCLM);2024-05-16